Core Viewpoint - The Gross Law Firm is notifying shareholders of Telix Pharmaceuticals Ltd. regarding a class action lawsuit due to alleged misleading statements made by the company during a specified period [1][3]. Group 1: Allegations - The complaint alleges that during the class period from February 21, 2025, to August 28, 2025, Telix Pharmaceuticals made materially false and misleading statements regarding its prostate cancer therapeutic candidates [3]. - It is claimed that the company overstated the progress made with its therapeutic candidates and the quality of its supply chain and partners [3]. - As a result of these misstatements, the company's statements about its business, operations, and prospects were deemed materially false and misleading [3]. Group 2: Class Action Details - Shareholders who purchased shares of TLX during the class period are encouraged to register for the class action, with a deadline set for January 9, 2026 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [4]. - There is no cost or obligation for shareholders to participate in this case [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that led to stock inflation [5].
Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX